title: Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma.
authors.forename: Andrés J M
authors.initials: AJ
authors.lastname: Ferreri
authors.forename: Marta
authors.initials: M
authors.lastname: Bruno Ventre
authors.forename: Giovanni
authors.initials: G
authors.lastname: Donadoni
authors.forename: Chiara
authors.initials: C
authors.lastname: Cattaneo
authors.forename: Luca
authors.initials: L
authors.lastname: Fumagalli
authors.forename: Marco
authors.initials: M
authors.lastname: Foppoli
authors.forename: Silvia
authors.initials: S
authors.lastname: Mappa
authors.forename: Silvia
authors.initials: S
authors.lastname: Govi
authors.forename: Massimo
authors.initials: M
authors.lastname: Di Nicola
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Rossi
authors.forename: Umberto
authors.initials: U
authors.lastname: Tirelli
authors.forename: Federico
authors.initials: F
authors.lastname: Caligaris-Cappio
authors.forename: Michele
authors.initials: M
authors.lastname: Spina
authors.forename: Alessandro
authors.initials: A
authors.lastname: Re
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002051:Burkitt Lymphoma / Q000150:complications / Q000628:therapy*; D002330:Carmustine / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006679:HIV Seropositivity / Q000150:complications / Q000628:therapy*; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D011034:Podophyllotoxin / Q000008:administration & dosage; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous
chemical_list: D003561:Cytarabine; D011034:Podophyllotoxin; D008558:Melphalan; D002330:Carmustine